Payload Information
General Information of This Payload
| Payload ID | PAY0BATPH |
|||||
|---|---|---|---|---|---|---|
| Name | FD6 |
|||||
| Synonyms |
FD6
Click to Show/Hide
|
|||||
| Target | DNA topoisomerase I (TOP1) | |||||
| Structure |
|
|||||
| Formula | C21H19FN4O4 |
|||||
| Isosmiles | CC[C@]1(O)C(C=C2C3=NC4=CC(F)=C(N)C=C4C(CN)=C3CN52)=C(COC1=O)C5=O |
|||||
| PubChem CID | ||||||
| InChI |
InChI=1S/C21H19FN4O4/c1-2-21(29)13-4-17-18-11(7-26(17)19(27)12(13)8-30-20(21)28)10(6-23)9-3-15(24)14(22)5-16(9)25-18/h3-5,29H,2,6-8,23-24H2,1H3/t21-/m0/s1
|
|||||
| InChIKey |
RTHVXOWSCOVBGA-NRFANRHFSA-N
|
|||||
| Pharmaceutical Properties | Molecule Weight |
410.405 |
Polar area |
133.46 |
||
Complexity |
1294.333573 |
xlogp Value |
1.2596 |
|||
Heavy Count |
30 |
Rot Bonds |
2 |
|||
Hbond acc |
8 |
Hbond Donor |
3 |
|||
The activity data of This Payload
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
38354417 T-DL13 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.003 nM
|
High HER2 expression (HER2 +++) | ||
| Method Description |
A total of 30,000 SK-BR-3 (HER2-high) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative HER2 expression (HER2-) | ||
| Method Description |
A total of 10,000 MDA-MB-468 (HER2-negative) cells were seeded either as monocultures or cocultures in TC-treated 48-well microtiter plates (Greiner Bio-One, catalog no. 667180) and treated with 1.0 or 0.1 nmol/L ADCs diluted in growth medium.
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
References